Click Therapeutics and Otsuka Pharmaceutical announce FDA clearance for Rejoyn for treating major depressive disorder
Mental Health Tech
Apr 1, 2024
Funding
InStride Health raises USD 30 million in Series B funding to enhance clinical quality and expand to new markets
Mental Health Tech
Mar 26, 2024
Funding
Brightside Health raises USD 33 million in Series C funding to expand its product offerings and market reach
Mental Health Tech
Mar 26, 2024
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.